CellRapeutics™ Leukopak from Inflammatory Bowel Disease Donor (XS-0426-XU283)

Name: CellRapeutics™ Leukopak from Inflammatory Bowel Disease Donor
SKU: XS-0426-XU283
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This Leukopak is harvested from donors diagnosed with Inflammatory Bowel Disease. The specimen contains a diverse array of gut-homing lymphocytes and activated innate immune cells involved in mucosal barrier failure. It provides a comprehensive platform for high-throughput screening of immunomodulators and the study of the systemic leukocyte trafficking that drives intestinal autoimmunity.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Inflammatory Bowel Disease Donor

Cat. No.
XS-0426-XU283

Donor Age
Young Adult, Middle-Aged

Donor Health
Diagnosed with IBD. The cell population reflects a broad state of gastrointestinal immune dysregulation, featuring high frequencies of mucosal-homing effector lymphocytes and activated innate immune subsets.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, optimized to stabilize the pro-inflammatory vs. regulatory immune cell ratio during processing.

Additional Donor Information
Each lot features a Leukopak from donors with IBD. Profiles include disease phenotype and history of biologic therapies, providing a diverse leukocyte pool for inflammatory signaling studies.

Clinical Profile
Specific diagnosis, disease location, current severity, and history of biologics or immunosuppressants.

Additional Information

Medication History
Available upon request. Records of 5-ASAs, corticosteroids, and history of biological therapies or conventional immunosuppressants.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Inflammatory Bowel Disease Donor, Leukopak, Inflammatory Bowel Disease

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Inflammatory Bowel Disease Donor (XS-0426-XU283). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.